That’s pretty much sums it up.

Hopefully the new FDA is looking for solutions rather than adhering to their pre-set targets!!!

Clinical trials should be more like upside down pyramids, aiming for multiple targets & hoping to hit at least one with high clarity!!!

Considering the primary end point as the deal breaker is truly old school and backward thinking!!!